LOGIN
Local Injection of Ketorolac vs Triamcinolone Acetonide for De Quervain's Tenosynovitis
November 2022
Local Injection of Ketorolac vs Triamcinolone Acetonide for De Quervain's Tenosynovitis
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1
Comparison of the effect of ketorolac versus triamcinolone acetonide injections for the treatment of de Quervain's tenosynovitis: a double-blind randomized controlled trial
BMC Musculoskelet Disord. 2022 Sep 1;23(1):831.Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
Sixty-four patients with de Quervain's tenosynovitis were randomized to receive a local injection of ketorolac (n=31) or triamcinolone acetonide (n=33). Outcomes of interest included pain scores on a Visual Numeric Rating Scale (VNRS), the Disabilities of the Arm, Shoulder and Hand (DASH) score, grip strength and pinch strength, and the need for additional injection, assessed at 6 weeks follow up....
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Join the Conversation
Please Login or Join to leave comments.